Details for Patent: 6,113,920
✉ Email this page to a colleague
Summary for Patent: 6,113,920
Title: | Pharmaceutical compositions |
Abstract: | A pharmaceutical composition and a method of inhibiting human immunodeficiency virus (HIV) is disclosed which comprises administering to an HIV infected patient a homogenous combination of lamivudine, zidovudine and a pharmaceutical glidant in an amount which achieves antiviral efficacy. |
Inventor(s): | Maye; Katherine Jeannette (Durham, NC), Goodson; Gary Wayne (Raleigh, NC), Wood; Allen Wayne (Cary, NC) |
Assignee: | Glaxo Wellcome Inc. (Research Triangle Park, NC) |
Application Number: | 08/955,635 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Use; |
Drugs Protected by US Patent 6,113,920
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,113,920
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 9622681 | Oct 31, 1996 |
International Family Members for US Patent 6,113,920
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 1067 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 9901519 | ⤷ Try a Trial | |||
Argentina | 009135 | ⤷ Try a Trial | |||
Austria | 241364 | ⤷ Try a Trial | |||
Australia | 5314298 | ⤷ Try a Trial | |||
Australia | 736607 | ⤷ Try a Trial | |||
Bulgaria | 103435 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |